Lv51
870 积分 2022-11-05 加入
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases
5小时前
待确认
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
5小时前
待确认
PPARα is a key regulator of hepatic FGF21
5小时前
待确认
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammation
5小时前
待确认
A comprehensive review on alpha-lipoic acid delivery by nanoparticles
5小时前
待确认
Understanding the influence of experimental factors on bio-interactions of nanoparticles: Towards improving correlation between in vitro and in vivo studies
5小时前
待确认
Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties
5小时前
待确认
Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane
5小时前
待确认
Digestive Enzyme Corona Formed in the Gastrointestinal Tract and Its Impact on Epithelial Cell Uptake of Nanoparticles
5小时前
待确认
皖公网安备34019202002308
